Enhanced Genomics
British BioTech company innovating 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases
Enhanced Genomics has raised €16M across 1 funding round from 3 investors, most recently a Series A round in Sep 2025. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.
Cambridge, UKenhancedgenomics.com ↗
Total raised
€16M
€16,000,000
Funding rounds
1
Investors
3
distinct backers
Active since
2025-09
latest 2025-09
Funding by year
EUR raised per yearEnhanced Genomics — funding by year — interactive chart.
Data table
| Enhanced Genomics — funding by year | |
|---|---|
| 2025 | €16M |
Signals
High confidenceRaise-next likelihood58
base rate 44% for Series A
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-17 | Series A | €16M | BGF,Meltwind,Parkwalk Advisors | View deal → |